Talk:Neprilysin

A fact from Neprilysin appeared on Wikipedia's Main Page in the Did you know column on 12 March 2007. The text of the entry was as follows:

Did you know... that the enzyme neprilysin (pictured) degrades amyloid beta, a peptide whose abnormal aggregation is implicated as a cause of Alzheime's disease?

A record of the entry may be seen at Wikipedia:Recent additions/2007/March.

Wikipedia

Molecular Biology: MCB

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Untitled[edit]

Is CD 10 the same as Common Acute Lymphoblastic Leukemia Antigen (CALLA)? If so, wouldn't this be an important thing to mention in the article? —Preceding unsigned comment added by 68.73.149.236 (talk) 04:06, 30 October 2007 (UTC)[reply]

It is and it would be. I'm going to fix this but it should probably go into more depth about its role as a tumor marker. Kajerm 19:21, 1 November 2007 (UTC)[reply]

A user tried to modify this page stating that: 02:01, 28 March 2011 Oreilles (talk | contribs) m (9,207 bytes) (the caption to the figure "normal kidney" is incorrect: it is severely abnormal kidney with probably tubulo-interstitial disease. I do not see how to change the caption myself.) but was unable to do so appropriately, can this be checked?

"Cornerstone" of treatment in heart failure[edit]

https://jamanetwork.com/journals/jama/fullarticle/2768982
Heart Failure With Reduced Ejection Fraction: A Review
Sean P. Murphy, MB, BCh, BAO1; Nasrien E. Ibrahim, MD2,3; James L. Januzzi Jr, MD2,3,4
JAMA. 2020;324(5):488-504.
August 4, 2020
doi:10.1001/jama.2020.10262

"The cornerstone of guideline-directed medical therapy for HFrEF involves inhibition of the renin-angiotensin-aldosterone and sympathetic nervous systems and augmentation of favorable pathways with inhibition of neprilysin, a neutral endopeptidase that degrades several peptides involved in regulating cardiovascular and renal homeostasis and metabolism."

--Nbauman (talk) 04:50, 17 August 2020 (UTC)[reply]